Fig. 4

Association between the TyG index (T3 vs. T1) and NAFLD in each subgroups. Adjusted, if not stratified, for age, gender, AF type, dyslipidemia, diabetes, BMI, eGFR, AST, ALT, HDL-C, UA, duration of AF, hypertension, and smoking. NAFLD non-alcoholic fatty liver disease, 95% CI 95% confidence interval, OR odds ratio, TyG triglyceride–glucose, BMI body mass index, eGFR estimated glomerular filtration rate, AST aspartate aminotransferase, ALT alanine aminotransferase, HDL-C high-density lipoprotein cholesterol, UA uric acid